Madrigal Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
300.83
|
|
Average Rating
|
4.38
|
|
# Strong Buys
|
7
|
|
# Buys
|
4
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-4.15
|
-4.75
|
-0.60
|
-14.46%
|
|
2022-06-30
|
-3.70
|
-4.14
|
-0.44
|
-11.89%
|
|
2022-03-31
|
-3.62
|
-3.36
|
0.26
|
7.18%
|
|
2021-12-31
|
-3.88
|
-3.78
|
0.10
|
2.58%
|
|
2021-09-30
|
-3.90
|
-3.79
|
0.11
|
2.82%
|
|
2021-06-30
|
-3.58
|
-3.72
|
-0.14
|
-3.91%
|
|
2021-03-31
|
-3.84
|
-3.32
|
0.52
|
13.54%
|
|
2020-12-31
|
-3.85
|
-3.82
|
0.03
|
0.78%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-12.25
|
|
2021-12-31
|
-14.61
|
|
2020-12-31
|
-13.09
|
|
2019-12-31
|
-5.45
|
|
2018-12-31
|
-2.21
|
|
2017-12-31
|
-2.54
|
|
2016-12-31
|
-4.71
|
|
2015-12-31
|
-19.25
|
|
2014-12-31
|
-31.50
|
|
2013-12-31
|
-44.45
|
|
2012-12-31
|
-37.10
|
|
2011-12-31
|
-38.15
|
|
2010-12-31
|
-32.33
|
|
2009-12-31
|
81.55
|
|
2008-12-31
|
-95.90
|
|
2007-12-31
|
-69.30
|
|
2006-12-31
|
-20.90
|